Overview
Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain
Status:
Recruiting
Recruiting
Trial end date:
2022-06-01
2022-06-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Randomized control trial that to comparison the efficacy of injectable fentanyl in sublingual route versus oral morphine syrup for breakthrough pain in gynecologic cancer patients with chronic cancer pain Primary outcome : to measure pain score after drug is givenPhase:
Phase 1/Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Rajavithi HospitalTreatments:
Fentanyl
Morphine
Criteria
Inclusion Criteria:- Gynecologic cancer patients with chronic cancer pain that use opioid drug for basal
pain
Exclusion Criteria:
- allergy in fentanyl or morphine
- abnormal cognitive function patient